Allergan PLC (AGN)

AGN (NYSE:Drugs) EQUITY
$228.89
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | AGN Avg Daily Volume: 5,303,700
Last Update: 05/24/16 - 4:00 PM EDT
Volume: 0
YTD Performance: -26.76%
Open: $0.00
Previous Close: $228.89
52 Week Range: $195.50 - $340.34
Oustanding Shares: 395,556,908
Market Cap: 89,202,038,323
6-Month Chart
TheStreet Ratings Grade for AGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 10 9 9
Moderate Buy 3 3 2 2
Hold 4 4 0 0
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 1.75 1.75 1.42 1.42
Latest Dividend: 0.05
Latest Dividend Yield: 0.08%
Dividend Ex-Date: 02/25/15
Price Earnings Ratio: 18.14
Price Earnings Comparisons:
AGN Sector Avg. S&P 500
18.14 21.00 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-19.60% -24.05% 79.90%
GROWTH 12 Mo 3 Yr CAGR
Revenue 15.40 1.60 0.36
Net Income 0.00 -30.20 0.00
EPS 0.00 12.00 1.33
Earnings for AGN:
EBITDA 5.36B
Revenue 15.07B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $3.37 $3.65 $14.18 $17.36
Number of Analysts 8 7 11 11
High Estimate $3.67 $3.85 $14.78 $18.14
Low Estimate $3.14 $3.49 $13.70 $16.92
Prior Year $4.41 $3.48 $13.43 $14.18
Growth Rate (Year over Year) -23.58% 5.01% 5.57% 22.42%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Doug Kass

 | May 24, 2016 | 4:07 PM EDT
The U.S. dollar rallied strongly. And stocks lost their correlation to the currency, rising dramatically. Crude oil advanced by 60 cents to $48.68. But nat gas dropped by six cents. Gold declined by more than $22 an ounce; I cautioned about the precious metal yesterday. Again, participants "off sides" much like equities today.  Agricultural commodities were mixed: wheat +2.75, corn +0.75, soybean -2.25, oats -.50. Lumber rose by $2.50 following the buoyant housing data. Bonds fell. Dennis Gartman had quite negative comments on fixed income in his daily letter today. The yield on the 10-year note rose by one basis point to 1.85% and the long bond was flat at 2.63% despite a successful two-year auction. Municipals were well-bid. Closed-end muni bond funds continued toward their second daily advance. High yield was also stronger. Blackstone/GSO Strategic Credit Fund (BGB) sprinted up nearly 1%. Banks flourished with talk of a June/July rate hike and, perhaps, a few more later in the year. Insurance rallied. I added to long Hartford Financial Services Group (HIG). Brokerages rose but failed to rally as hard as the overall market. Retail was weak, though Home Depot (HD) rose $2. Best Buy (BBY) was a feature to downside after disappointing guidance. Surprisingly, my two shorts -- Foot Locker (FL) and Nordstrom (JWN) -- were marginally lower. Old tech was led by Microsoft (MSFT), which caught an analyst upgrade at Cowen and rose $1.50. IBM (IBM) was up a similar amount. Media was up, but marginally. Disney (DIS) and Comcast (CMCSA) were up 50 cents each. Energy stocks underperformed. My short Exxon Mobil (XOM) was up a quarter and short Schlumberger (SLB) rose 60 cents. Staples were higher. Autos were ahead, but small and non-threatening to the shorts. Ford (F) was up 15 cents and General Motors (GM) up 35 cents. Biotech, my new long target, rallied. iShares Nasdaq Biotechnology ETF (IBB) was up $5. Buys Allergan (AGN) gained $3.60, Celgene (CELG) rose $2.35, Gilead Sciences (GILD) was up $2.70 and Intrexon (XON) was up 70 cents.  Ag equipment was well-bid. Caterpillar (CAT) was up 40 cents and Deere (DE) gained $1.40. (T)FANG was marvelous. Strong gains in Netflix (NFLX), Alphabet (GOOGL), Amazon (AMZN) and Facebook (FB). NOSH was strong as investors/traders gobbled up O'Reilly Automotive (ORLY) and HD. CRABBY's six components were higher. In terms of individual stocks, Apple (AAPL) continued its ascent, rising $1.30. Potash (POT), which I sold yesterday, was conspicuously weaker despite Monsanto's (MON) $3 gain. Twitter (TWTR) hit new lows. Oaktree Capital Group (OAK) rallied; I added at low levels today and over last few days. DuPont (DD) is the "world's fair," hitting another new high and up 85 cents. Here are some value-added columns posted on Real Money Pro today: Jim "El Capitan" Cramer on Catalyst City.  Tim "Not Judy or Phil" Collins on an interesting comparison between U.S. Oil Fund (USO) and Alerian MLP (AMLP).  Bret "Meet George" Jensen says take a chill pill.  Tim Melvin on three interesting small bank ideas. Rev Shark gets Billy Joel on us -- it's all just a matter of trust.
By

Doug Kass

 | May 24, 2016 | 1:56 PM EDT
I added to my longs of Hartford Financial (HIG) and Oaktree Capital (OAK). I substantially increased my short of th
By

Doug Kass

 | May 24, 2016 | 12:47 PM EDT
A Possible Double Bottom. After a brutal nine-month period of underperformance, the iShares Nasdaq Biotechnology ETF (IBB) appears to have possibly put in a "double bottom." The ETF breached $400 to the upside 10 months ago before tumbling to around $249 intraday on May 12. But today, IBB was up some $4 at last check to about $270. A Successful Test of 2014's Low? Besides a potential double bottom, IBB might have made a successful test of an important low going back to 2014, as this chart suggests. Rotation Opportunity? My expectation is that the U.S. dollar might experience renewed strength over the near term. If so, a rotation out of commodities, industrials and other resource sectors might move money back into former market leaders like biotech.
By

Doug Kass

 | May 23, 2016 | 3:03 PM EDT
The U.S. dollar weakened modestly after two days of strengthening following the Fed's remarks. Crude oil fell by 40 cents to $48. Nat gas was flat. Gold was down $1.60, recovering from the day's lows. Agricultural commodities: wheat -4.75, corn +2.50, soybeans -14.25 and oats flat. Lumber -9.20. Bonds rallied in price. The yield on the 10-year U.S. note down by one basis point to  1.83% and the long bond down two basis points to 2.62%. Municipals were up small but closed-end muni bond funds rallied nicely from the recent carnage. High yield was flat. Banks flat-lined and I remain cautious. Deutsche Bank (DB) is under $17, again. A concern. Insurers were down large fractions. Brokerages were mixed. Retail was up and down, but nothing major. My three shorts are Starbucks (SBUX), up a dime, Nordstrom (JWN), up 20 cents, and Foot Locker (FL), down 55 cents. Old media and old tech did little. Energy was unchanged, though Schlumberger (SLB) caught a recommendation from the Buy Side. SLB was down 20 cents and Exxon Mobil (XOM) was up 20 cents. Autos continue to roll over. Ag equipment was strong, with Deere (DE) up 60 cents and Caterpillar (CAT) up 75 cents. Consumer nondurables were slightly better, despite my protestations! Biotech couldn't hold its morning gains, though iShares Nasdaq Biotechnology ETF (IBB) nonetheless was up $2.60. Allergan (AGN) and Valeant (VRX) -- the object of my recent disaffection -- were lower, off $4.10 and $1.10, respectively. My former speculative biotech package was up marginally.  (T)FANG was mixed, with Tesla (TSLA) down $3, Facebook (FB) down $1.10, Amazon (AMZN) down $3 and Netflix (NFLX) up $1.75. NOSH was weighed down by O'Reilly Automotive (ORLY), down $2. CRABBY was settled, with little price change on the day. In terms of individual stocks, Apple (AAPL) was up $1.60 (continuing its Berkshire-inspired rally from last week -- yawn!), POT was up 60 cents on the Monsanto (MON) takeover news, and Oaktree Capital Group (OAK) was down 50 cents. Here is some good stuff from Real Money Pro today: Jim "El Capitan" Cramer on McDonald's (MCD) and PepsiCo (PEP).  Tim "Not Judy or Phil" Collins chimes in on gold.  Bob Lang on "The Bear Market."  Rev Shark on something strange in the neighborhood (and it isn't ghosts).  Bret Jensen on two promising biopharmas.
By

Jim Cramer

 | May 16, 2016 | 11:28 AM EDT

Jim Cramer says he wouldn't be surprised if Allergan looked at buying Anacor before Pfizer decided to acquire the company for $5.2 billion, including debt.

By

Doug Kass

 | May 13, 2016 | 8:51 AM EDT
AAPL made another near-term low, trading briefly under $90. It was down 2.35% on the day, but Apple announced a $1 billion investment in Chinese ride-sharing company Didi Chuxing. Is CEO Tim Cook serious? Monsanto (MON) became a possible takeover target of two different German companies. This led me to re-establish a medium-sized position in rival fertilizer company Potash Corp. (POT). I plan to buy more at current prices today. I did no trading yesterday other than buying some POT. :) I remain manifestly bearish and deep into the ursine territory. My net-short exposure is as high as it's been in two years. The S&P 500 futures were down 3.5 points at last check, indicating more selling pressure in today's regular session. The U.S. dollar strengthened. Oil fell 55 cents to $46.15 a barrel. Gold lost three beaners to $1,268 an ounce. Among agricultural commodities, wheat was -1, corn -1 and soybeans -4.50. Lumber was unchanged. Bonds were lower in price, with the iShares 20+ Year Treasury Bond ETF (TLT) losing $0.57. But 10- and 30-year U.S. Treasury yields both added two basis points. Municipal bonds were well bid, but closed-end muni funds were mixed. High-yield debt was slightly higher. The iShares iBoxx U.S. Dollar High Yield Corporate Bond ETF (HYG) finished +$0.09 and the SPDR Barclays High Yield Bond ETF (JNK) added $0.03. The Blackstone/GSO Strategic Credit closed-end fund (BGB) finished the day three pennies higher. Bank stocks were flat to lower, but brokerage stocks got hit -- led by a two-beaner drop in Goldman Sachs (GS). Insurers were slightly higher, with Geico/General Re parent Berkshire Hathaway (BRK.A, BRK.B) recovering from recent weakness. Old tech ended mixed. Energy was stronger again,

bullishAllergan added to Conviction Buy List at Goldman

May 13, 2016 | 7:04 AM EDT

AGN was placed on the Conviction Buy list, according to Goldman Sachs. $275 price target. Company can deliver double-digit sales growth and is buying back stock. 

By

Bob Byrne

 | May 13, 2016 | 7:00 AM EDT

Despite increased volume and volatility, Thursday was anything but easy to navigate.

By

David Katz

 | May 12, 2016 | 8:00 AM EDT

Despite an earnings beat and upbeat outlook, its stock has suffered with other drug makers.

By

Jim Cramer and Jack Mohr

 | May 11, 2016 | 1:00 PM EDT

The company hit all the major points of investor concern.

We knew what the trading world was looking at in recent weeks.  It was the famous head an...
I've already posted this on twitter.  This is just a reminder that even though AAPL is ra...
Under Armour (UA) is getting lots of press today after signing "The largest revenue contra...
FIBOCALL: XLF- Are you a BUYER today? The XLF is flirting with the 100 Week Moving Average...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.